Clinical Trial Oversight for Sponsors

Tuesday 28th April 2026 2pm GMT (15:00 CET and 9.00 EST)

Regulators expect sponsors to demonstrate clear, consistent oversight of their clinical trials — but what are the key requirements and how are they best implemented? This course will cover regulatory and practical aspects of sponsor oversight in a 1.5-hour webinar.  Expectations outlined in the recently implemented ICH E6(R3) Annex 1 and upcoming up for more complex studies in ICH E6(R3) Annex 2 will be covered along with case studies, hints, tips  and tools for demystifying how to apply good sponsor oversight.

Key highlights:

·        Recent revisions to ICH E6(R3) Annex 1 impacting sponsor oversight of clinical trials

·        Anticipated additional sponsor oversight considerations for complex trials in ICH E6(R3) Annex 2

·        Practical tips for implementation of risk based oversight tools

The webinar is ideal for sponsors involved in the design, set up, conduct, monitoring, auditing, and analysis of clinical trials involving medicinal products globally.  Researchers, CROs, consultants, healthcare professionals, and service providers would also benefit for this webinar.

Prior basic knowledge of basic GCP is advised but is not essential. The course will consist of presentations and poll questions.  

Our normal webinar pricing applies:

• Individual connections (single participant): £200
• Single connection with up to 5 people taking part – note one connection only): £350
• Single connection with 5+ people taking part – note one connection only): £500
• Special rates available for organisations needing multiple connections - please contact us for details